A Safety Study of SGN-40 in Patients With Non-Hodgkin's Lymphoma

Clinical trial NCT00103779 · COMPLETED

Trial details

NCT number: NCT00103779
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma

Start date: 2004-12-01
Primary completion: 2007-03-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.